Garcovich, M;
Zocco, MA;
Roccarina, D;
Ponziani, FR;
Gasbarrini, A;
(2012)
Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota.
World Journal of Gastroenterology
, 18
(46)
p. 6693.
10.3748/wjg.v18.i46.6693.
Preview |
Text
WJG-18-6693.pdf - Published Version Download (708kB) | Preview |
Abstract
The gut flora plays an important role in the pathogenesis of the complications of cirrhosis. Hepatic encephalopathy (HE) represents a broad continuum of neuropsychological dysfunction in patients with acute or chronic liver disease and/or porto-systemic shunting of blood flow and it manifests with progressive deterioration of the superior neurological functions. The pathophysiology of this disease is complex, as it involves overproduction and reduced metabolism of various neurotoxins, particularly ammonia. Management of HE is diversified and requires several steps: elimination of precipitating factors, removal of toxins, proper nutritional support, modulation of resident fecal flora and downregulation of systemic and gut-derived inflammation. This review will provide an overview of gut barrier function and the influence of gut-derived factors on HE, focusing on the role of gut microbiota in the pathogenesis of HE and the recent literature findings on its therapeutic manipulation.
| Type: | Article |
|---|---|
| Title: | Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3748/wjg.v18.i46.6693 |
| Publisher version: | http://dx.doi.org/10.3748/wjg.v18.i46.6693 |
| Language: | English |
| Additional information: | Articles published by this open-access journal are distributed under the terms of the Creative Commons Attribution-Noncommercial (CC BY-NC 4.0) License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. |
| Keywords: | Hepatic encephalopathy; Gut microbiota; Cirrhosis; Non-absorbable disaccharides; Rifaximin |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10042238 |
Archive Staff Only
 |
View Item |
